Compare Biocon with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ABBOTT INDIA BIOCON /
ABBOTT INDIA
 
P/E (TTM) x 41.4 47.2 87.8% View Chart
P/BV x 5.4 14.7 36.8% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 BIOCON    ABBOTT INDIA
EQUITY SHARE DATA
    BIOCON
Mar-21
ABBOTT INDIA
Mar-21
BIOCON /
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs48818,569 2.6%   
Low Rs27513,970 2.0%   
Sales per share (Unadj.) Rs59.22,028.2 2.9%  
Earnings per share (Unadj.) Rs7.7325.0 2.4%  
Cash flow per share (Unadj.) Rs13.7352.4 3.9%  
Dividends per share (Unadj.) Rs0275.00 0.0%  
Avg Dividend yield %01.7 0.0%  
Book value per share (Unadj.) Rs62.31,203.7 5.2%  
Shares outstanding (eoy) m1,200.0021.25 5,647.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.48.0 80.2%   
Avg P/E ratio x49.450.1 98.7%  
P/CF ratio (eoy) x27.946.2 60.4%  
Price / Book Value ratio x6.113.5 45.3%  
Dividend payout %084.6 0.0%   
Avg Mkt Cap Rs m457,350345,717 132.3%   
No. of employees `000NANA-   
Total wages/salary Rs m17,4104,927 353.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m71,05843,100 164.9%  
Other income Rs m6,052835 725.1%   
Total revenues Rs m77,11043,935 175.5%   
Gross profit Rs m13,1459,189 143.1%  
Depreciation Rs m7,151581 1,230.2%   
Interest Rs m577183 315.6%   
Profit before tax Rs m11,4699,260 123.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2152,353 94.2%   
Profit after tax Rs m9,2546,907 134.0%  
Gross profit margin %18.521.3 86.8%  
Effective tax rate %19.325.4 76.0%   
Net profit margin %13.016.0 81.3%  
BALANCE SHEET DATA
Current assets Rs m76,00435,185 216.0%   
Current liabilities Rs m42,10110,309 408.4%   
Net working cap to sales %47.757.7 82.7%  
Current ratio x1.83.4 52.9%  
Inventory Days Days1374 3,061.3%  
Debtors Days Days632 2,951.7%  
Net fixed assets Rs m106,1423,041 3,490.1%   
Share capital Rs m6,000213 2,823.5%   
"Free" reserves Rs m68,72825,366 270.9%   
Net worth Rs m74,72825,579 292.1%   
Long term debt Rs m29,6160-   
Total assets Rs m182,14638,226 476.5%  
Interest coverage x20.951.7 40.4%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.41.1 34.6%   
Return on assets %5.418.5 29.1%  
Return on equity %12.427.0 45.9%  
Return on capital %11.536.9 31.3%  
Exports to sales %00.7 0.0%   
Imports to sales %7.212.3 58.1%   
Exports (fob) Rs mNA295 0.0%   
Imports (cif) Rs m5,0845,306 95.8%   
Fx inflow Rs m11,791353 3,336.4%   
Fx outflow Rs m5,0845,389 94.3%   
Net fx Rs m6,707-5,035 -133.2%   
CASH FLOW
From Operations Rs m11,5977,267 159.6%  
From Investments Rs m-36,247-718 5,046.9%  
From Financial Activity Rs m25,640-5,818 -440.7%  
Net Cashflow Rs m723731 98.9%  

Share Holding

Indian Promoters % 39.7 0.0 -  
Foreign collaborators % 20.9 75.0 27.9%  
Indian inst/Mut Fund % 24.0 7.7 309.8%  
FIIs % 15.6 0.2 7,100.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 25.0 157.4%  
Shareholders   347,911 90,567 384.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex, Nifty End Marginally Lower; Metal Stocks Witness Selling(Closing)

After opening on a positive note, Indian share markets failed to keep up early gains and ended the day marginally lower.

Related Views on News

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


May 23, 2022 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS